Literature DB >> 23869572

The changing face of acoustic neuroma management in the USA: analysis of the 1998 and 2008 patient surveys from the acoustic neuroma association.

Jaymin Patel1, Rohit Vasan, Harry van Loveren, Katheryne Downes, Siviero Agazzi.   

Abstract

OBJECTIVE: A recent review of the national cancer center registry Surveillance Epidemiology and End Results (SEER) database revealed that in the United States, 25% of Acoustic Neuromas (AN) are managed with observation. Several articles have questioned the aggressive treatment of these slow growing tumors. Concern has been raised that data from the SEER database might be biased towards treatment as patients who chose observation are less likely to be seen at a cancer center. To try and adjust for this potential bias, we decided to investigate management trends of AN in the United States using patient surveys conducted by the Acoustic Neuroma Association (ANA). Study design. Database review.
METHODS: Data from the 1998 and 2008 ANA patient's surveys were analyzed to detect trends between tumor size and treatment modality. Management trends including observation, microsurgical resection and radiation were examined as well based on tumor size criteria.
RESULTS: During this study period, tumor size at diagnosis decreased significantly (1966-1998: 23.8% ≤ 1.5 cm; 1999-2008: 45.3% ≤ 1.5 cm). The use of microsurgery decreased from 92.7% to 53.4%, while the use of radiosurgery/radiotherapy increased from 5% to 24.2% and observation increased to 22.4%.
CONCLUSION: Review of data from the ANA confirmed that radiosurgery, and watch and wait are gaining popularity as treatment options. Regardless of this shift in tumor management, microsurgery continues to be the primary method of treatment across tumor sizes in the United States of America and observation remains the least common management modality.

Entities:  

Mesh:

Year:  2013        PMID: 23869572     DOI: 10.3109/02688697.2013.815323

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  11 in total

1.  Modern trends in the management of head and neck paragangliomas.

Authors:  Carlos Suárez; Verónica Fernández-Alvarez; Hartmut P H Neumann; Carsten C Boedeker; Christian Offergeld; Alessandra Rinaldo; Primož Strojan; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12       Impact factor: 2.503

2.  The impact of MRI steady-state sequences as an additional assessment modality in vestibular schwannoma patients after LINAC stereotactic radiotherapy or radiosurgery.

Authors:  Julian P Sauer; Thomas M Kinfe; Bogdan Pintea; Andreas Schäfer; Jan P Boström
Journal:  Strahlenther Onkol       Date:  2018-05-23       Impact factor: 3.621

3.  Main Symptom that Led to Medical Evaluation and Diagnosis of Vestibular Schwannoma and Patient-Reported Tumor Size: Cross-sectional Study in 1,304 Patients.

Authors:  Maria Peris-Celda; Christopher S Graffeo; Avital Perry; Panagiotis Kerezoudis; Nicole M Tombers; Matthew L Carlson; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2018-10-09

4.  Experience of multidisciplinary team meetings in vestibular schwannoma: a preliminary report.

Authors:  Clémentine Daveau; Sandra Zaouche; Emmanuel Jouanneau; Véronique Favrel; Séverine Artru; Christian Dubreuil; Stéphane Tringali
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

5.  The changing landscape of vestibular schwannoma diagnosis and management: A cross-sectional study.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Ronald Sahyouni; Autefeh Sajjadi; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope       Date:  2019-04-05       Impact factor: 3.325

6.  Modern Gamma Knife radiosurgery of vestibular schwannomas: treatment concept, volumetric tumor response, and functional results.

Authors:  Samuel M Lipski; Motohiro Hayashi; Mikhail Chernov; Marc Levivier; Yoshikazu Okada
Journal:  Neurosurg Rev       Date:  2014-12-19       Impact factor: 3.042

7.  Merlin-Deficient Schwann Cells Are More Susceptible to Radiation Injury than Normal Schwann Cells In Vitro.

Authors:  Erin Cohen; Stefanie Pena; Christine Mei; Olena Bracho; Brian Marples; Nagy Elsayyad; Stefania Goncalves; Michael Ivan; Paula V Monje; Xue-Zhong Liu; Cristina Fernandez-Valle; Fred Telischi; Christine T Dinh
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-19

Review 8.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

9.  Stability and survival of bone-anchored hearing aid implant systems in post-irradiated patients.

Authors:  Mark D Wilkie; Kathryn A Lightbody; Ali A Salamat; Kalyan M Chakravarthy; David A Luff; Robert H Temple
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-17       Impact factor: 2.503

10.  Deafness and sickle cell disease: three case reports and review of the literature.

Authors:  Payal Desai; Marjorie Dejoie-Brewer; Samir K Ballas
Journal:  J Clin Med Res       Date:  2014-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.